5,7-dihydroxy-2-(1-hydroxy-3,5-dimethoxy-4-oxocyclohexa-2,5-dien-1-yl)-4H-chromen-4-one

Metabolite details

Identifier

CFHMXDWFWXOTEE-UHFFFAOYSA-N

InChI Key

CFHMXDWFWXOTEE-UHFFFAOYSA-N

IUPAC name

5,7-dihydroxy-2-(1-hydroxy-3,5-dimethoxy-4-oxocyclohexa-2,5-dien-1-yl)chromen-4-one

Preferred name

5,7-dihydroxy-2-(1-hydroxy-3,5-dimethoxy-4-oxocyclohexa-2,5-dien-1-yl)-4H-chromen-4-one

INN name

—

Synonym

—

ChEBI

CHEBI:193175

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_0d_vs_Treatment_180d